Vascular stem cells and ischaemic retinopathies

Area of Science:

• Ophthalmology
• Vascular Biology
• Regenerative Medicine

Background:

• Retinal ischaemic disorders, including diabetic retinopathy and retinal vein occlusion, are prevalent causes of vision loss.
• Hypoxia in the retina triggers neovascularization and leakage, leading to macular edema and blindness.
• Current treatments for ischaemic retinopathies have significant side effects.

Purpose of the Study:

• To review the potential of endothelial progenitor cells (EPCs) for treating retinal ischaemic disorders.
• To explore the molecular and phenotypic characteristics of EPCs and their role in vascular repair.
• To provide a rationale for using EPCs as a therapeutic strategy for ischaemic retinopathies.

Main Methods:

• Literature review of experimental and clinical studies on retinal ischaemia and EPCs.
• Analysis of the molecular and phenotypic properties of EPCs.
• Examination of EPC alterations in disease states.

Main Results:

• Evidence suggests reperfusion of ischaemic retina and suppression of sight-threatening sequelae are achievable.
• Endothelial progenitor cells (EPCs) demonstrate potential for promoting vascular repair in the retina.
• EPCs have shown promise in reversing ischaemic injury in various tissues.

Conclusions:

• Reparative intra-retinal angiogenesis, particularly using EPCs, offers a potential alternative to current therapies.
• Further research into the clinical application of EPCs is warranted to address remaining questions.
• EPCs may provide a novel therapeutic option for managing ischaemic retinopathies and preventing blindness.